With $50M, Flagship Pioneering makes another big RNA play

Following on the success of its messenger RNA company, Moderna Inc. (Nasdaq: MRNA), and its newer "endless RNA" company, Laronde, Cambridge venture capital and creation firm Flagship Pioneering is betting on another RNA biotechnology: transfer RNA.